Late Breaking Abstract - Analysis of volatile organic compounds in post-COVID-19 patients with eNose technology.

B. van Raaij (Leiden, Netherlands), J. Hameete (Leiden, Netherlands), J. Stöger (Leiden, Netherlands), M. Ninaber (Leiden, Netherlands), J. Geelhoed (Leiden, Netherlands)

Source: Virtual Congress 2021 – Back to infection basics
Session: Back to infection basics
Session type: E-poster
Number: 2364

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. van Raaij (Leiden, Netherlands), J. Hameete (Leiden, Netherlands), J. Stöger (Leiden, Netherlands), M. Ninaber (Leiden, Netherlands), J. Geelhoed (Leiden, Netherlands). Late Breaking Abstract - Analysis of volatile organic compounds in post-COVID-19 patients with eNose technology.. 2364

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Comprehensive analysis of volatile organic compounds in human breath gas samples
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020


Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Late Breaking Abstract - Differences in flavorant levels and synthetic coolant use between USA, EU and Canadian Juul products
Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation
Year: 2020




Interpretation of exhaled volatile organic compounds
Source: Eur Respir Monogr 2010; 49: 115-129
Year: 2010


Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Late Breaking Abstract - Impact of an improvised system on preserving oxygen supplies in patients with COVID-19.
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


Late Breaking Abstract - Capnography for ultimately simple diagnostics of COPD
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017



Airborne concentration of limonene (a volatile organic compound (VOC)), when using a spray of 41 essential oils
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013

The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose®
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018




Late Breaking Abstract - Development and validation of an automated radiomic CT signature for detecting?COVID-19
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020



Late Breaking Abstract - Exploring particles from exhaled air as a new source for protein biomarkers from the airways
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017